Dysregulation of CaMKII has been observed in neurological diseases including ADHD (Yabuki et al., 2014), Parkinson’s disease (Zaichick et al., 2017), and Alzheimer’s disease (Ghosh and Giese, 2015). Here, CAMK2G is linked to Alzheimer disease.